PDCD1LG2 and neoplasm: The involvement of PD-1 with its PD-L1 and PD-L2 ligands, which are expressed by antigen-presenting cells and may be expressed by tumor cells and/or other cells in the tumor microenvironment, results in inhibition of the T-cell function, such as proliferation, cytokine secretion, and cytotoxic activity.